These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 22664532

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
    Zhu D, Wan X, Huang H, Chen X, Liang W, Zhao F, Lin T, Han J, Xie W.
    Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040
    [Abstract] [Full Text] [Related]

  • 3. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
    Su J, Wu S, Tang W, Qian H, Zhou H, Guo T.
    Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.
    Chiba T, Miyagi S, Saraya A, Aoki R, Seki A, Morita Y, Yonemitsu Y, Yokosuka O, Taniguchi H, Nakauchi H, Iwama A.
    Cancer Res; 2008 Oct 01; 68(19):7742-9. PubMed ID: 18829528
    [Abstract] [Full Text] [Related]

  • 6. FoxG1 interacts with Bmi1 to regulate self-renewal and tumorigenicity of medulloblastoma stem cells.
    Manoranjan B, Wang X, Hallett RM, Venugopal C, Mack SC, McFarlane N, Nolte SM, Scheinemann K, Gunnarsson T, Hassell JA, Taylor MD, Lee C, Triscott J, Foster CM, Dunham C, Hawkins C, Dunn SE, Singh SK.
    Stem Cells; 2013 Jul 01; 31(7):1266-77. PubMed ID: 23592496
    [Abstract] [Full Text] [Related]

  • 7. Enhancing the therapeutic effect via elimination of hepatocellular carcinoma stem cells using Bmi1 siRNA delivered by cationic cisplatin nanocapsules.
    Yang T, Chen Y, Zhao P, Xue H, You J, Li B, Liu Y, He C, Zhang X, Fan L, Lee RJ, Li L, Ma X, Xu C, Xiang G.
    Nanomedicine; 2018 Oct 01; 14(7):2009-2021. PubMed ID: 29842934
    [Abstract] [Full Text] [Related]

  • 8. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
    Xu Y, Jiang Z, Zhang Z, Sun N, Zhang M, Xie J, Li T, Hou Y, Wu D.
    J Cell Biochem; 2014 Jun 01; 115(6):1112-21. PubMed ID: 24356998
    [Abstract] [Full Text] [Related]

  • 9. BMI1 sustains human glioblastoma multiforme stem cell renewal.
    Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G.
    J Neurosci; 2009 Jul 15; 29(28):8884-96. PubMed ID: 19605626
    [Abstract] [Full Text] [Related]

  • 10. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
    Teshima K, Nara M, Watanabe A, Ito M, Ikeda S, Hatano Y, Oshima K, Seto M, Sawada K, Tagawa H.
    Oncogene; 2014 Apr 24; 33(17):2191-203. PubMed ID: 23686310
    [Abstract] [Full Text] [Related]

  • 11. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
    Li R, Huang J, Ma M, Lou Y, Zhang Y, Wu L, Chang DW, Zhao P, Dong Q, Wu X, Han B.
    Oncotarget; 2016 Oct 18; 7(42):68360-68370. PubMed ID: 27588392
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation.
    Srinivasan M, Bharali DJ, Sudha T, Khedr M, Guest I, Sell S, Glinsky GV, Mousa SA.
    Oncotarget; 2017 Jun 13; 8(24):38731-38742. PubMed ID: 28418883
    [Abstract] [Full Text] [Related]

  • 13. Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma.
    Hao C, Liu G, Tian G.
    Ther Adv Respir Dis; 2019 Jun 13; 13():1753466619866097. PubMed ID: 31368411
    [Abstract] [Full Text] [Related]

  • 14. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells.
    Vora P, Seyfrid M, Venugopal C, Qazi MA, Salim S, Isserlin R, Subapanditha M, O'Farrell E, Mahendram S, Singh M, Bakhshinyan D, Chokshi C, McFarlane N, Dvorkin-Gheva A, Brown KR, Murty N, Moffat J, Bader GD, Singh SK.
    J Neurooncol; 2019 Jul 13; 143(3):417-428. PubMed ID: 31115870
    [Abstract] [Full Text] [Related]

  • 15. Mutated p53 Promotes the Symmetric Self-Renewal of Cisplatin-Resistant Lung Cancer Stem-Like Cells and Inhibits the Recruitment of Macrophages.
    Xu Y, Xu Z, Li Q, Guo L, Wang Y, Zhou J, Wang G, Liu Y.
    J Immunol Res; 2019 Jul 13; 2019():7478538. PubMed ID: 31781681
    [Abstract] [Full Text] [Related]

  • 16. Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer.
    Zhang Y, Wang Z, Yu J, Shi Jz, Wang C, Fu Wh, Chen Zw, Yang J.
    Cancer Lett; 2012 Sep 01; 322(1):70-7. PubMed ID: 22343321
    [Abstract] [Full Text] [Related]

  • 17. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid in vitro and in vivo.
    Li W, Yan R, Liu Y, He C, Zhang X, Lu Y, Khan MW, Xu C, Yang T, Xiang G.
    Drug Deliv; 2019 Dec 01; 26(1):794-802. PubMed ID: 31366257
    [Abstract] [Full Text] [Related]

  • 18. Short hairpin RNA targeting AKT1 and PI3K/p85 suppresses the proliferation and self-renewal of lung cancer stem cells.
    Jiang AG, Lu HY, Zhang DG, Zhang LX, Gao XY.
    Mol Med Rep; 2015 Jul 01; 12(1):363-70. PubMed ID: 25738369
    [Abstract] [Full Text] [Related]

  • 19. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression.
    Gopinath S, Malla R, Alapati K, Gorantla B, Gujrati M, Dinh DH, Rao JS.
    Carcinogenesis; 2013 Mar 01; 34(3):550-9. PubMed ID: 23222817
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.
    Luo H, Yang R, Li C, Tong Y, Fan L, Liu X, Xu C.
    Tumour Biol; 2017 Jul 01; 39(7):1010428317718414. PubMed ID: 28720065
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.